Latest & greatest articles for myocardial infarction

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on myocardial infarction or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on myocardial infarction and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for myocardial infarction

1. Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial. Full Text available with Trip Pro

Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial. To test a scalable health system intervention to improve long term adherence to secondary prevention treatments among patients who have had a recent myocardial infarction.Three arm, pragmatic randomised controlled trial with blinded outcome assessment.Nine cardiac centres in Ontario, Canada.2632 patients with obstructive coronary artery (...) disease after a myocardial infarction, identified from a centralised cardiac registry.Participants were randomised 1:1:1 to receive usual care, five mail-outs developed through a user centred design process, or mail-outs plus phone calls. The phone calls were delivered first by an interactive automated system to screen for non-adherence to treatment. Trained lay health workers followed up as necessary. Interventions were coordinated centrally but delivered from each patient's hospital site.Co-primary

2020 BMJ

2. Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation Full Text available with Trip Pro

Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes (...) Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Acad Emerg Med Actions . 2020 Mar 27. doi: 10.1111/acem.13922. Online ahead of print. Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 From the, Emergency Medicine, Baylor College of Medicine, Houston, TX. 2 the, Department

2020 EvidenceUpdates

3. Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population

Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Am J Cardiol Actions . 2020 Jun 15;125(12):1823-1828. doi: 10.1016/j.amjcard.2020.03.026. Epub 2020 Apr 10. Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population , , , Affiliations Expand Affiliations 1 Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina. 2 Department of Internal Medicine, Section on Hospital

2020 EvidenceUpdates

4. Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis. Full Text available with Trip Pro

Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis. To evaluate the prognosis of unrecognised myocardial infarction determined by electrocardiography (UMI-ECG) or cardiac magnetic resonance imaging (UMI-CMR).Systematic review and meta-analysis of prospective studies.Electronic databases, including PubMed, Embase, and Google Scholar.Prospective cohort studies were included if they reported (...) adjusted relative risks, odds ratios, or hazard ratios and 95% confidence intervals for all cause mortality or cardiovascular outcomes in participants with unrecognised myocardial infarction compared with those without myocardial infarction.The primary outcomes were composite major adverse cardiac events, all cause mortality, and cardiovascular mortality associated with UMI-ECG and UMI-CMR. The secondary outcomes were the risks of recurrent coronary heart disease or myocardial infarction, stroke, heart

2020 BMJ

5. Management of Acute Myocardial Infarction During the COVID?19 Pandemic Full Text available with Trip Pro

Management of Acute Myocardial Infarction During the COVID?19 Pandemic Management of acute myocardial infarction during the COVID‐19 pandemic - Mahmud - - Catheterization and Cardiovascular Interventions - Wiley Online Library COVID-19 campus closures: see options for to subscribed content. By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Core Curriculum Free Access Management of acute myocardial infarction during (...) is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID‐19 pandemic. It is critical to inform the public that we can minimize exposure to the coronavirus so they continue to call the emergency medical system (EMS) for acute ischemic heart disease symptoms and therefore get the appropriate level of cardiac care that their presentation warrants; target the use of primary percutaneous coronary intervention (PCI) or fibrinolysis

2020 Society for Cardiovascular Angiography and Interventions

6. Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial Full Text available with Trip Pro

Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show (...) . doi: 10.1016/j.jacc.2020.01.050. Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial , , , , , , , , , , , , , , , , , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators Yoga-CaRe Trial Investigators : , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations 1 Centre for Chronic Disease Control, New Delhi, India; Public Health Foundation of India, New Delhi, India; London School of Hygiene

2020 EvidenceUpdates

7. Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial

Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial Exercise Intervention Improves Quality of Life in Older Adults After Myocardial Infarction: Randomised Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily (...) Create file Cancel Actions Cite Share Permalink Copy Page navigation Heart Actions . 2020 Mar 6;heartjnl-2019-316349. doi: 10.1136/heartjnl-2019-316349. Online ahead of print. Exercise Intervention Improves Quality of Life in Older Adults After Myocardial Infarction: Randomised Clinical Trial , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy cmpglc@unife.it. 2 Cardiology Unit, Azienda Ospedaliera

2020 EvidenceUpdates

8. Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study

Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- To 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed (...) any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation Ann Emerg Med Actions . 2020 Feb 8;S0196-0644(19)31440-4. doi: 10.1016/j.annemergmed.2019.12.008. Online ahead of print. Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- To 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study , , , , , , , , Affiliations

2020 EvidenceUpdates

9. Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome

Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features (...) management software Create file Cancel Actions Cite Share Permalink Copy Page navigation J Am Coll Cardiol Actions . 2020 Mar 17;75(10):1095-1106. doi: 10.1016/j.jacc.2019.12.067. Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome , , , , , , , , Affiliations Expand Affiliations 1 TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

2020 EvidenceUpdates

10. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. (Abstract)

Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. Acute myocardial infarction (AMI) complicated by cardiogenic shock is associated with substantial morbidity and mortality. Although intravascular microaxial left ventricular assist devices (LVADs) provide greater hemodynamic support as compared with intra (...) microaxial LVAD use only, IABP only, other (such as use of a percutaneous extracorporeal ventricular assist system, extracorporeal membrane oxygenation, or a combination of MCS device use), or medical therapy only.The primary outcomes were in-hospital mortality and in-hospital major bleeding.Among 28 304 patients undergoing PCI for AMI complicated by cardiogenic shock, the mean (SD) age was 65.0 (12.6) years, 67.0% were men, 81.3% had an ST-elevation myocardial infarction, and 43.3% had cardiac arrest

2020 JAMA

11. Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes (Abstract)

Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes Patients with diabetes mellitus (DM) have elevated levels of high-sensitivity cardiac troponin (hs-cTn). We investigated the diagnostic performance of the European Society of Cardiology (ESC) algorithms to rule out or rule in acute myocardial infarction (AMI) without ST-elevation in patients with DM.We prospectively enrolled 3,681 patients

2020 EvidenceUpdates

12. Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study. (Abstract)

Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study. Older adults with acute myocardial infarction (AMI) have higher prevalence of functional impairments, including deficits in cognition, strength, and sensory domains, than their younger counterparts.To develop and evaluate the prognostic utility of a risk model for 6-month post-AMI mortality in older adults that incorporates information about functional impairments.Prospective cohort

2020 Annals of Internal Medicine

13. Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared with Females without Breast Cancer

Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared with Females without Breast Cancer Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared With Females Without Breast Cancer - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other (...) characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Am J Med Actions 2019 Nov 9 [Online ahead of print] Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared With Females Without Breast Cancer , , , , , , , , , , Affiliations Expand Affiliations 1 Division of Cardiology. 2

2020 EvidenceUpdates

14. Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49)

Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49) Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49) - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy (...) , Emory University School of Medicine, Atlanta, Georgia. 9 Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. PMID: 31870492 DOI: Item in Clipboard Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49) C Michael Gibson et al. Am J Cardiol . 2019 Show details Am J Cardiol Actions Authors , , , , , , , , , , , , , Affiliations 1 Cardiovascular Division

2020 EvidenceUpdates

15. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial

Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features (...) a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation J Am Coll Cardiol Actions , 74 (22), 2713-2723 2019 Dec 3 Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Centre

2020 EvidenceUpdates

16. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54 Full Text available with Trip Pro

Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54 Long-term Ticagrelor for Secondary Prevention in Patients With Prior Myocardial Infarction and No History of Coronary Stenting: Insights From PEGASUS-TIMI 54 - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go (...) your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Eur Heart J Actions 2019 Dec 7 [Online ahead of print] Long-term Ticagrelor for Secondary Prevention in Patients With Prior Myocardial Infarction and No History of Coronary Stenting: Insights From PEGASUS-TIMI 54

2020 EvidenceUpdates

17. Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction

Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library of Medicine National Center (...) to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation J Am Coll Cardiol Actions , 74 (21), 2572-2584 2019 Nov 26 Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

2020 EvidenceUpdates

18. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial

Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features (...) Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Interventional Cardiology Department, Cardiovascular Institute, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain (M.S., S.B.). 2 Hospital Universitario de La Princesa, Madrid, Spain (F.A., J.C.). 3 Hospital Universitario de Bellvitge, IDIBELL, Barcelona, Spain (A.C., J.A.G.H.). 4 Hospital San Pedro de Alcántara

2020 EvidenceUpdates

19. ACC, SCAI, ACEP Release Consensus Statement on Management of acute myocardial infarction Patients During COVID-19

ACC, SCAI, ACEP Release Consensus Statement on Management of acute myocardial infarction Patients During COVID-19 Management of Acute Myocardial Infarction During the COVID-19 Pandemic | JACC: Journal of the American College of Cardiology Advertisement User menu Source Search for this keyword Search Source Search for this keyword Search Journal of the American College of Cardiology DOI: 10.1016/j.jacc.2020.04.039 Just Accepted Management of Acute Myocardial Infarction During the COVID-19 (...) -19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy

2020 American College of Cardiology

20. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. Full Text available with Trip Pro

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. Experimental and clinical evidence supports the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.We performed a randomized, double-blind trial involving patients recruited within 30 days after a myocardial infarction. The patients were randomly assigned to receive either low (...) -dose colchicine (0.5 mg once daily) or placebo. The primary efficacy end point was a composite of death from cardiovascular causes, resuscitated cardiac arrest, myocardial infarction, stroke, or urgent hospitalization for angina leading to coronary revascularization. The components of the primary end point and safety were also assessed.A total of 4745 patients were enrolled; 2366 patients were assigned to the colchicine group, and 2379 to the placebo group. Patients were followed for a median

2019 NEJM